Successful long-term ibrutinib treatment in a hemodialysis patient with leukemic non-nodal mantle cell lymphoma

We report the first case of long-term ibrutinib administration in a hemodialysis patient with leukemic non-nodal mantle cell lymphoma (L-NN-MCL) in which ibr utinib therapy was both safe and effective.

Source: Clinical Lymphoma, Myeloma and Leukemia - October 8, 2020 Category: Hematology Authors: Hajime Yasuda, Yutaka Tsukune, Tadaaki Inano, Yosuke Mori, Yasunori Ota, Norio Komatsu Tags: Case Report Source Type: research